Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bayer HealthCare launches lab-sharing scheme with start-up firms

Bayer HealthCare launches lab-sharing scheme with start-up firms

17th January 2012

Bayer HealthCare has announced the launch of a new programme that will see it sharing laboratory space with promising start-up life science companies.

The CoLaborator scheme will involve the introduction of a 550 sq m lab area at its Mission Bay site in the US, which will be shared with up-and-coming firms with technology platforms, drug targets or drug candidates that align with Bayer's portfolio.

Housing three to four small companies, the CoLaborator facility will help researchers to establish a foothold in business by offering them support and expertise, while Bayer will be given preferred access to partner with the new companies.

A late summer 2012 launch has been outlined for the scheme and will continue Bayer's recent efforts to expand its research model.

Professor Dr Andreas Busch, head of global drug discovery at Bayer HealthCare, said: "The CoLaborator is a natural extension of our unique approach to research partnerships where we recognise that innovation is a collaborative process and focus on sharing risks and rewards."

Last month, Bayer and its partner Janssen announced the submission of a European regulatory application for Xarelto in a new indication for acute coronary syndrome.ADNFCR-8000103-ID-801266377-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.